Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 21, 2015; 21(35): 10080-10090
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10080
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10080
Table 1 Relative content of GM3, GD3 and GD1a gangliosides in intestinal mucosa
Control (BAP)(n = 6) | Control (CRC)(n = 12) | IBD(n = 11) | PooledSEM | |
GM3 | 27.5a | 24.4a | 48.6b | 3.8 |
GD3 | 26.3 | 39.4 | 31.4 | 2.4 |
GD1a | 38.0c | 31.7c | 11.6d | 2.6 |
Table 2 Quantitative content GM3 and GD3 gangliosides in intestinal mucosa
Control (BAP) (n = 6) | Control (CRC) (n = 12) | IBD(n = 11) | Pooled SEM | |
GM3 | ||||
μg/g tissue | 2.4a,b | 1.0a | 5.8b | 0.8 |
μg/g protein | 62.3c,d | 19.2c | 77.8d | 14.1 |
mg/mol PL | 317.7 | 379.2 | 196.9 | 67.7 |
GD3 | ||||
μg/g tissue | 1.4 | 1.6 | 1.4 | 0.2 |
μg/g protein | 36.8 | 31.3 | 20.2 | 6.1 |
mg/mol PL | 38.1 | 17.7 | 15.4 | 3.0 |
GM3/GD3 | ||||
Tissue | 1.7a | 1.4a | 5.6b | 0.90 |
Protein | 1.8a | 1.5a | 5.6b | 0.90 |
PL | 8.4a | 19.3 b | 20.1b | 2.40 |
Table 3 Relative content of unsaturated bonds in GM3, GD3 and GD1a gangliosides in intestinal mucosa
Unsaturated Bonds | Control (BAP) (n = 6) | Control (CRC) (n = 12) | IBD(n = 11) | Pooled SEM | |
GM3 | 0 | 5.73a | 2.77b | 3.3a,b | 0.41 |
1 | 69.96 | 73.40 | 68.34 | 1.30 | |
2 | 21.86 | 21.62 | 25.24 | 1.05 | |
3 | 2.45 | 2.22 | 3.10 | 0.21 | |
UI | 1.21 | 1.23 | 1.28 | 0.07 | |
GD3 | 0 | 9.28 | 6.18 | 5.91 | 1.18 |
1 | 59.39c | 58.67c | 87.88d | 2.91 | |
2 | 28.28c | 32.98c | 6.21d | 2.45 | |
3 | 3.09c | 2.18c | NDd | 0.30 | |
UI | 1.25c | 1.31c | 1.00d | 0.17 | |
GD1a | 0 | 5.32a,b | 6.8a | 3.11b | 0.68 |
1 | 64.95c | 59.26c | 89.93d | 3.05 | |
2 | 26.21c | 30.51c | 8.06d | 2.44 | |
3 | 3.55c | 3.43c | NDd | 0.44 | |
UI | 1.28c | 1.31c | 1.06d | 0.17 |
Table 4 Relative content of individual GM3, GD3 and GD1a ganglioside species in intestinal mucosa
Ceramide | Control (BAP) (n = 6) | Control (CRC) (n = 12) | IBD(n = 11) | Pooled SEM | |
GD3 | 43:0 | 8.4c | 5.2c | NDd | 0.7 |
34:1 | 8.9c | 8.2c | 20.2d | 1.6 | |
36:1 | 2.4a | 4.0a | 6.0b | 0.4 | |
38:1 | 2.9c | 3.9c | 10.8d | 0.8 | |
40:1 | 14.2c | 15.9c | 48.4d | 3.3 | |
42:1 | 24.8c | 22.0c | NDd | 2.3 | |
40:2 | 1.0c | 1.1c | 3.67d | 0.3 | |
42:2 | 26.8c | 31.8c | NDd | 2.9 | |
42:3 | 3.1c | 2.4c | NDd | 0.3 | |
GD1a | 43:0 | 4.3c | 3.0c | NDd | 0.4 |
34:1 | 6.5a | 3.1a | 12.0b | 1.1 | |
36:1 | 16.9 | 14.8 | 24.0 | 2.3 | |
38:1 | 8.7c | 8.8c | 19.3d | 1.3 | |
40:1 | 13.1c | 13.9c | 33.9d | 2.4 | |
42:1 | 15.3c | 15.1c | NDd | 1.8 | |
40:2 | 2.0a | 1.7a | 4.3b | 0.4 | |
42:2 | 22.2c | 28.5c | NDd | 2.7 | |
42:3 | 3.5c | 3.4c | NDd | 0.4 |
Table 5 Unsaturated ceramide species of phosphatidylcholine in intestinal mucosa
Unsaturated Bonds | Control (BAP)(n = 6) | Control (CRC)(n = 12) | IBD(n = 11) | Pooled SEM |
0 | 9.82 | 10.05 | 12.43 | 0.76 |
1 | 6.14 | 7.77 | 8.8 | 0.59 |
2 | 53.78 | 54.57 | 58.87 | 1.69 |
> 2 | 30.26a | 27.61a | 19.9b | 1.38 |
UI | 2.33a | 2.27b | 2.06b | 0.03 |
- Citation: Miklavcic JJ, Hart TD, Lees GM, Shoemaker GK, Schnabl KL, Larsen BM, Bathe OF, Thomson AB, Mazurak VC, Clandinin MT. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease. World J Gastroenterol 2015; 21(35): 10080-10090
- URL: https://www.wjgnet.com/1007-9327/full/v21/i35/10080.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i35.10080